CRH Medical Corporation Common Shares of Beneficial Interest (CRHM): Price and Financial Metrics
GET POWR RATINGS... FREE!
CRHM Stock Summary
- CRHM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 4.58 -- higher than merely 23.9% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of CRH Medical Corp's sales and general administrative expense to its total operating expenses; only 11.93% of US stocks have a lower such ratio.
- Over the past twelve months, CRHM has reported earnings growth of -272.08%, putting it ahead of merely 7.18% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to CRH Medical Corp, a group of peers worth examining would be PED, KLXE, AEMD, SNDL, and LBRT.
- CRHM's SEC filings can be seen here. And to visit CRH Medical Corp's official web site, go to investors.crhsystem.com.
CRHM Stock Price Chart Interactive Chart >
CRHM Price/Volume Stats
|Current price||$3.99||52-week high||$4.01|
|Prev. close||$3.99||52-week low||$1.66|
|Day high||$4.00||Avg. volume||1,043,867|
|50-day MA||$3.92||Dividend yield||N/A|
|200-day MA||$2.77||Market Cap||285.76M|
CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Company Bio
CRH Medical Corporation, a medical company, provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company was founded in 2000 and is based in Vancouver, Canada.
CRHM Latest News Stream
|Loading, please wait...|
CRHM Latest Social Stream
View Full CRHM Social Stream
Latest CRHM News From Around the Web
Below are the latest news stories about CRH Medical Corp that investors may wish to consider to help them evaluate CRHM as an investment opportunity.
WELL Health Technologies announced that on April 16, shareholders of CRH Medical Corporation (CRH) voted in favor of WELL's acquisition of CRH for $4 per share in cash. This is WELL Health’s (WELL) largest acquisition to-date, with a transaction value of approximately $369.2 million. The deal is expected to close on or around April 22. CRH Medical provides products and services to gastroenterologists throughout the United States. WELL Health Chairman and CEO Hamed Shahbazi said, "Once the acquisition is completed, CRH represents a significant opportunity for WELL as it will significantly boost WELL's revenue, and profitability and provides, WELL with additional inorganic and organic growth opportunities including a meaningful channel of over 3000 physicians to offer its digital tools, t...
CRH Medical (CRHM) securityholders approve the acquisition of CRH by a subsidiary of WELL Health Technologies.Upon closing of the arrangement, CRH shareholders will receive $4 per common share in cash, less any applicable withholding taxes.Transaction is expected to be completed on or about April 22, 2021.Press Release...
CRH Medical Corporation ([[CRHM]]) has completed the acquisition of the remaining 25% interest in Lake Lanier Anesthesia Associates increasing its ownership at Georgia-based gastroenterology anesthesia practice to 100%.The transaction funded through CRH's credit facility and cash on hand is expected to raise adjusted operating EBITDA attributable to CRH Medical shareholders, the company...
CRH Medical Corporation Announces Purchase of Remaining Ownership in Lake Lanier Anesthesia Associates
CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has completed an accretive transaction whereby the Company has acquired the remaining 25% interest in Lake Lanier Anesthesia Associates ("LLAA") a gastroenterology anesthesia practice located in Georgia. CRH initially acquired 75% of LLAA in June of 2020.This transaction will increase adjusted operating EBITDA attributable to shareholders, as CRH now owns 100% of LLAA. This transaction was financed through a combination of CRH's credit facility and cash on hand.
CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in Middle Arkansas Sedation Associates, LLC ("MASA"), a gastroenterology anesthesia practice located in Little Rock, Arkansas.
CRHM Price Returns